The present invention provides novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind to a chemokine receptor, and which affect the binding of the natural ligand or chemokine to a receptor such as CXCR4 of a target cell.
本发明提供了一种新型化合物,它们以一种与
趋化因子受体结合的方式对目标细胞表现出对HIV感染的保护作用,并影响
天然配体或
趋化因子与目标细胞的CXCR4等受体的结合。